From: Integrating multi-cohort machine learning and clinical sample validation to explore peripheral blood mRNA diagnostic biomarkers for prostate cancer
PCa
BPH
Number of patients
42
30
Age (year), median (range)
67.33 (46–75)
66.27 (51–87)
PSA (ng/mL)
 0–4
0
3
 4–10
25
20
 > 10
17
7
ISUP
 1
2
 2
19
 3
10
 4
6
 5
5